Tag: Anthera Pharmaceuticals

March 6, 2018

Anthera Pharmaceuticals Provides Business Update and Reports 2017 Fourth Quarter and Fiscal Year Financial Results

Anthera Pharmaceuticals (Nasdaq:ANTH) today provided a business update and reported financial results for the fourth quarter and fiscal year ending...
January 25, 2018

Anthera Receives Positive Nasdaq Listing Determination

Anthera Pharmaceuticals (Nasdaq:ANTH) today announced that on January 24, 2018, Anthera received formal notice that the Nasdaq Hearings Panel granted Anthera’s...
January 22, 2018

Anthera Announces Positive Outcome of Second Interim Futility Analysis in the Phase 3 RESULT Clinical Study of Sollpura

Anthera Pharmaceuticals (Nasdaq:ANTH) today announced a positive outcome of the second, pre-specified interim futility analysis for the RESULT Phase 3...
April 10, 2017

Anthera Finished Dosing In Clinical Study

Anthera Pharmaceuticals completed the dosing of a recent randomized, double-blind, placebo-controlled clinical study of blisibimod on patients with Berger's disease.